ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2024

SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome.

Brandon D Beers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.